Cite
MLA Citation
Hasumati Rahalkar et al.. “Biosimilar development and review process in the BRICS-TM countries: Proposal for a standardized model to improve regulatory performance.” Expert review of clinical pharmacology, vol. 15, no. 2, 2022, pp. 215–236. http://access.bl.uk/ark:/81055/vdc_100153000745.0x000009